Ignite Creation Date:
2024-05-06 @ 2:41 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02105623
Status:
TERMINATED
Last Update Posted:
2018-06-25
First Post:
2014-04-03
Brief Title:
EARly Prevention of aTHeroma Progression
Sponsor:
CHEOL WHAN LEE MD PhD
Organization:
Asan Medical Center
Study Overview
Official Title:
EARly Prevention of aTHeroma Progression
Status:
TERMINATED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Slow enrollement Low Follow-up rate
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EARTH
Brief Summary:
The purpose of this study is to compare standard therapy risk factor control life style modification versus standard therapy plus low-dose rosuvastatin therapy 5mgday on progression of coronary atherosclerosis in statin naive individuals who have mild CAD nonobstructive coronary atherosclerotic plaques and normal LDL low-density lipoprotein cholesterol levels130mgdl
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None